The CRI Anna-Maria Kellen Clinical Accelerator leverages relationships with nonprofits and corporations to fund and deliver multi-center studies that one group or company could not achieve alone. Through these global partnerships and collaborations, the Clinical Accelerator is advancing ambitious clinical and translational research to cure cancer. Our partners provide instrumental support to the program by contributing strategic direction and managing the operations and logistics of our trials. Our collaborations provide critical funding and/or access to emerging technologies and agents. The Clinical Accelerator is proud to be supported by these outstanding organizations:


Nonprofit Collaborations

Biotech and Pharmaceutical Company Collaborations

*Immunotherapy results may vary from patient to patient.